jidjournal.bsky.social
In publication since 1904, JID is the premier global journal for original research on infectious diseases. JID is an official journal of @idsainfo.bsky.social
👤 Joined on 24 October 2023
Followers
Following
Total Posts
@jidjournal.bsky.socialWhat happens when an antiviral works by causing mutations? In a new Let’s Talk ID episode, JID Deputy Editor Jonathan Li, MD, FIDSA talks the science behind molnupiravir and a recent paper that raised questions about its potential effects in mammalian cells. Watch: www.idsociety.org/multimedia/p...
Show PostOn IDSA’s & HIVMA’s Science Speaks: Learn more about the efficacy of switching to doravirine/islatravir, how immunocompromised individuals hospitalized with COVID-19 remain at increased mortality risk and other research in @jidjournal.bsky.social to inform clinical practice. https://bit.ly/4AYYFzi
Show PostOn IDSA’s & HIVMA’s Science Speaks blog: Learn about the poor antimalarial efficacy of IPTp-SP, how starting HIV treatment in early life can significantly reduce the size of the HIV reservoir and other new research in JID that’s ready to inform clinical practice. https://bit.ly/3SI2GGA
Show PostIDSA has established a Journals Reader Panel where readers of cidjournal.bsky.social, ofidjournal.bsky.social and jidjournal.bsky.social can give direct feedback to our editors. Apply to join by March 31 to engage directly with editors, learn about new journal initiatives and more: bit.ly/406h4ZG
Show PostIDSA has established a Journals Reader Panel where readers of cidjournal.bsky.social, ofidjournal.bsky.social and jidjournal.bsky.social can give direct feedback to our editors. Apply to join by March 31 to engage directly with editors, learn about new journal initiatives and more: bit.ly/406h4ZG
Show Post